menu
    • menu
    [{"orgOrder":0,"company":"Kemin Foods LC","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Lutein","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Kemin Foods LC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Oil","sponsorNew":"Kemin Foods LC \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"Kemin Foods LC \/ Undisclosed"},{"orgOrder":0,"company":"Maastricht University Medical Center","sponsor":"Cognis Deutschland GmbH & Co. KG","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"NETHERLANDS","productType":"Plant Extract\/Herbal","year":"2010","type":"Inapplicable","leadProduct":"Lutein","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"Maastricht University Medical Center","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Maastricht University Medical Center \/ Cognis Deutschland GmbH & Co. KG","highestDevelopmentStatusID":"1","companyTruncated":"Maastricht University Medical Center \/ Cognis Deutschland GmbH & Co. KG"},{"orgOrder":0,"company":"Newtricious R&D BV","sponsor":"Sprim Advanced Life Sciences","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"NETHERLANDS","productType":"Plant Extract\/Herbal","year":"2012","type":"Inapplicable","leadProduct":"Lutein","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Undisclosed","graph3":"Newtricious R&D BV","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Newtricious R&D BV \/ Sprim Advanced Life Sciences","highestDevelopmentStatusID":"1","companyTruncated":"Newtricious R&D BV \/ Sprim Advanced Life Sciences"},{"orgOrder":0,"company":"Kemin Foods LC","sponsor":"Royal DSM","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2017","type":"Inapplicable","leadProduct":"Lutein","moa":"Undisclosed","graph1":"Nutrition and Weight Loss","graph2":"Undisclosed","graph3":"Kemin Foods LC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kemin Foods LC \/ Royal DSM","highestDevelopmentStatusID":"1","companyTruncated":"Kemin Foods LC \/ Royal DSM"},{"orgOrder":0,"company":"Bausch & Lomb Incorporated","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"CANADA","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Lutein","moa":"||Undisclosed","graph1":"Ophthalmology","graph2":"Approved FDF","graph3":"Bausch & Lomb Incorporated","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bausch & Lomb Incorporated \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Bausch & Lomb Incorporated \/ Undisclosed"},{"orgOrder":0,"company":"BioAdaptives","sponsor":"LY Research Corporation","pharmaFlowCategory":"D","therapeuticArea":"Ophthalmology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2023","type":"Licensing Agreement","leadProduct":"Lutein","moa":"||Undisclosed","graph1":"Ophthalmology","graph2":"Preclinical","graph3":"BioAdaptives","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"BioAdaptives \/ LY Research Corporation","highestDevelopmentStatusID":"4","companyTruncated":"BioAdaptives \/ LY Research Corporation"},{"orgOrder":0,"company":"Felipe Medeiros, MD","sponsor":"Heidelberg Engineering GmbH | MacuHealth | Industrial Org\u00e1nica S.A. de C.V.","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"","productType":"Plant Extract\/Herbal","year":"2019","type":"Inapplicable","leadProduct":"Lutein","moa":"Undisclosed","graph1":"Ophthalmology","graph2":"Phase I\/ Phase II","graph3":"Felipe Medeiros, MD","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Felipe Medeiros, MD \/ Heidelberg Engineering GmbH | MacuHealth | Industrial Org\u00e1nica S.A. de C.V.","highestDevelopmentStatusID":"7","companyTruncated":"Felipe Medeiros, MD \/ Heidelberg Engineering GmbH | MacuHealth | Industrial Org\u00e1nica S.A. de C.V."},{"orgOrder":0,"company":"VIST","sponsor":"European Regional Development Fund | Ministry of Education, Science and Sport, Republic of Slovenia | Dermatologija Bartenjev Rogl | Slovenian Research Agency | Valens Int. d.o.o., Slovenija","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Plant Extract\/Herbal","year":"2019","type":"Inapplicable","leadProduct":"Lutein","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"VIST","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"VIST \/ European Regional Development Fund | Ministry of Education, Science and Sport, Republic of Slovenia | Dermatologija Bartenjev Rogl | Slovenian Research Agency | Valens Int. d.o.o., Slovenija","highestDevelopmentStatusID":"1","companyTruncated":"VIST \/ European Regional Development Fund | Ministry of Education, Science and Sport, Republic of Slovenia | Dermatologija Bartenjev Rogl | Slovenian Research Agency | Valens Int. d.o.o., Slovenija"}]

    Find Clinical Drug Pipeline Developments & Deals for Lutein

    Menu

    Lutein

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Bausch & Lomb Incorporated

                            Canada arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Bausch & Lomb Incorporated

                            Canada arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein,Curcumin,Zeaxanthin

                            Therapeutic Area : Ophthalmology

                            Study Phase : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Bausch + Lomb Launches Blink NutriTears Supplement For Dry Eyes In US

                            Details : Blink NutriTears is a clinically proven nutritional supplement developed to help relieve dry eye symptoms. It contains a proprietary blend of lutein, zeaxanthin, curcumin, & vitamin D.

                            Product Name : Blink NutriTears

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            June 03, 2024

                            Lead Product(s) : Lutein,Curcumin,Zeaxanthin

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Approved FDF

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            BioAdaptives

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            BioAdaptives

                            U.S.A arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein,Astaxanthin

                            Therapeutic Area : Ophthalmology

                            Study Phase : Preclinical

                            Sponsor : LY Research Corporation

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            BioAdaptives Inc. Announced Today the Signing of a License for Eye Health due to Myopia and Presbyopia; a Pate...

                            Details : The agreement aims to market a patented product for Eye Health due to Myopia and Presbyopia. This Patent is a liposome and sustained release polymeric micelles preparation that improves the solubility of lutein.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Undisclosed

                            March 30, 2023

                            Lead Product(s) : Lutein,Astaxanthin

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Preclinical

                            Sponsor : LY Research Corporation

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Felipe Medeiros, MD

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Felipe Medeiros, MD

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein

                            Therapeutic Area : Ophthalmology

                            Study Phase : Phase I/ Phase II

                            Sponsor : Heidelberg Engineering GmbH | MacuHealth | Industrial Orgánica S.A. de C.V.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Macular Pigment and Visual Performance in Glaucoma Patients

                            Details : Lutein is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Glaucoma.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            May 22, 2019

                            Lead Product(s) : Lutein

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Phase I/ Phase II

                            Sponsor : Heidelberg Engineering GmbH | MacuHealth | Industrial Orgánica S.A. de C.V.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            VIST

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            VIST

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : European Regional Development Fund | Ministry of Education, Science and Sport, Republic of Slovenia | Dermatologija Bartenjev Rogl | Slovenian Research Agency | Valens Int. d.o.o., Slovenija

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Effect of 12-Week Dietary Intake of Lutein on Minimal Erythema Dose and Other Skin Parameters

                            Details : Lutein is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            January 22, 2019

                            Lead Product(s) : Lutein

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : European Regional Development Fund | Ministry of Education, Science and Sport, Republic of Slovenia | Dermatologija Bartenjev Rogl | Slovenian Research Agency | Valens Int. d.o.o., Slovenija

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Kemin Foods LC

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Kemin Foods LC

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of the Benefits of FloraGLOâ„¢ Lutein on Skin Health

                            Details : Floraglo Lutein is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Aging.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            December 10, 2018

                            Lead Product(s) : Lutein

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Kemin Foods LC

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Kemin Foods LC

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein

                            Therapeutic Area : Nutrition and Weight Loss

                            Study Phase : Undisclosed

                            Sponsor : Royal DSM

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Lutein on Visual Function

                            Details : Lutein is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Malnutrition.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            April 14, 2017

                            Lead Product(s) : Lutein

                            Therapeutic Area : Nutrition and Weight Loss

                            Highest Development Status : Undisclosed

                            Sponsor : Royal DSM

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            Newtricious R&D BV

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Newtricious R&D BV

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein

                            Therapeutic Area : Ophthalmology

                            Study Phase : Undisclosed

                            Sponsor : Sprim Advanced Life Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Intervention Trial in Early Age-related Macular Degeneration

                            Details : Lutein is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Wet Macular Degeneration.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            September 27, 2012

                            Lead Product(s) : Lutein

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Undisclosed

                            Sponsor : Sprim Advanced Life Sciences

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            Maastricht University Medical Center

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            Maastricht University Medical Center

                            Country arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lutein

                            Therapeutic Area : Ophthalmology

                            Study Phase : Undisclosed

                            Sponsor : Cognis Deutschland GmbH & Co. KG

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The Influence of Lutein Supplements on Age-related Macular Degeneration

                            Details : Lutein is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Macular Degeneration.

                            Product Name : Undisclosed

                            Product Type : Plant Extract/Herbal

                            Upfront Cash : Inapplicable

                            January 06, 2010

                            Lead Product(s) : Lutein

                            Therapeutic Area : Ophthalmology

                            Highest Development Status : Undisclosed

                            Sponsor : Cognis Deutschland GmbH & Co. KG

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth